[Current aspects of the treatment of acute leukemia].
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000150:complications; D002471:Cell Transformation, Neoplastic; D003630:Daunorubicin / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D007938:Leukemia / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D015122:Mercaptopurine / Q000627:therapeutic use; D008875:Middle Aged; D008938:Mitosis / Q000187:drug effects; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014750:Vincristine; D011239:Prednisolone; D015122:Mercaptopurine; D011241:Prednisone; D003630:Daunorubicin
Sovremennye aspekty lecheniia ostrogo leĭkoza.